| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |